Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Apiam Animal Health Ltd. ( (AU:AHX) ) has shared an announcement.
Apiam Animal Health has disclosed that director Professor Andrew Lancelot Vizard has ceased to hold 363,284 fully paid ordinary shares in the company. The change results in Vizard no longer holding any Apiam shares following completion of a corporate transaction.
The disposal of Vizard’s entire holding occurred as part of Apiam’s acquisition by Pepper Bidco Pty Ltd under a scheme of arrangement. This notice formalises the director’s change in interest, reflecting the transfer of ownership as the company moves under new control, with implications for the company’s governance and shareholder base.
The most recent analyst rating on (AU:AHX) stock is a Hold with a A$0.94 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page.
More about Apiam Animal Health Ltd.
Apiam Animal Health Limited is an Australian veterinary and animal health company focused on livestock and production animals. It provides veterinary services and related animal health solutions to rural and regional clients, positioning itself within the agribusiness and animal health services sector.
Average Trading Volume: 261,151
Technical Sentiment Signal: Buy
Current Market Cap: A$164.4M
See more insights into AHX stock on TipRanks’ Stock Analysis page.

